Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
1 | 40730735 | 0 | Camilli M, Occhipinti G, Potere N, et al. Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibition. J Thromb Thrombolysis. 2025 Jul 29. doi: 10.1007/s11239-025-03154-7. |
2 | 40673596 | 0 | Mahe I, Carrier M, Laporte S. Apixaban for Cancer-Associated Venous Thromboembolism. Reply. N Engl J Med. 2025 Jul 17;393(3):311-312. doi: 10.1056/NEJMc2506526. |
3 | 40673044 | 0 | Falanga A, Le Gal G, Carrier M, et al. Corrigendum: Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives. TH Open. 2025 Jul 10;9:s00451810091. doi: 10.1055/s-0045-1810091. eCollection 2025. |
4 | 40673042 | 0 | Pizzarossa AC, Penaloza A, Vrotniakaite-Bajerciene K, et al. Patient's Awareness of Cancer-Associated Thrombosis: A Canadian Nationwide Survey. TH Open. 2025 Jul 7;9:a26359296. doi: 10.1055/a-2635-9296. eCollection 2025. |
5 | 40668802 | 0 | Todorovski A, Wang TF, Sterling E, et al. Impact of clonal hematopoiesis of indeterminate potential on arterial atherothrombosis and venous thromboembolism: Protocol for a systematic review and meta-analysis. PLoS One. 2025 Jul 16;20(7):e0328650. doi: 10.1371/journal.pone.0328650. eCollection 2025. |
6 | 40606765 | 0 | Wang TF, Thomas M, Cervi A, et al. Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trial. Res Pract Thromb Haemost. 2025 May 23;9(4):102898. doi: 10.1016/j.rpth.2025.102898. eCollection 2025 May. |
7 | 40579365 | 0 | Khan F, Tritschler T, Marx CE, et al. Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis. Eur Heart J. 2025 Jun 22:ehaf453. doi: 10.1093/eurheartj/ehaf453. |
8 | 40500085 | 0 | Vrotniakaite-Bajerciene K, Carrier M, Wang TF. Risk Factors and Management of Cancer-Associated Thrombosis: The Ongoing Battle Between Efficacy and Safety of Anticoagulation. Med Clin North Am. 2025 Jul;109(4):857-873. doi: 10.1016/j.mcna.2025.01.004. Epub 2025 Apr 12. |
9 | 40449243 | 0 | Chornenki NLJ, Odabashian R, Carrier M, et al. All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a systematic review and meta-analysis. Thromb Res. 2025 May 24;252:109352. doi: 10.1016/j.thromres.2025.109352. |
10 | 40424644 | 0 | Ivankovic V, Noureldin A, Dainhi C, et al. High usability, low adoption: The struggle of a perioperative patient decision aid for extended thromboprophylaxis after major abdominal cancer surgery. Am J Surg. 2025 May 16;248:116415. doi: 10.1016/j.amjsurg.2025.116415. |